Expertise in
13
conditions

Dr. Eric M. Ruderman

Rheumatology
675 N St Clair St Ste 14-100, Galter Pavilion, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
35 Years of Experience
Referral may be required
Before you request
Expertise in
13
conditions
675 N St Clair St Ste 14-100, Galter Pavilion, 
Chicago, IL 

Overview

Eric Ruderman is a Rheumatologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 35 years.

Dr. Ruderman is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, Arthritis, and Tissue Biopsy.

Dr. Ruderman is board certified in American Board Of Internal Medicine - Rheumatology (Certified). He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 3 clinical trials. Dr. Ruderman is currently accepting new patients.

Graduate Institution

Albert Einstein College Of Medicine Of Yeshiva University

Specialties

Rheumatology

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Medicine - Rheumatology (Certified)

Fellowships

Brigham and Women's Hospital

Hospital Affiliations

Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Palos Community Hospital
Northwestern Medicine Delnor Community Hospital
Northwestern Medicine Central Dupage Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 15 Less Insurance Carriers -

Locations

675 N St Clair St Ste 14-100, Galter Pavilion, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Comparison of Tc 99m Tilmanocept Quantitative Imaging With Immunohistochemical (IHC) Analysis of CD206 Expression in Synovial Tissue From Subjects Clinically Diagnosed With Rheumatoid Arthritis (RA)
A Comparison of Tc 99m Tilmanocept Quantitative Imaging With Immunohistochemical (IHC) Analysis of CD206 Expression in Synovial Tissue From Subjects Clinically Diagnosed With Rheumatoid Arthritis (RA)
Enrollment Status: Terminated
Publish Date: January 08, 2025
Intervention Type: Drug
Study Drug: Tc 99m tilmanocept
Study Phase: Phase 2
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Etanercept, Adalimumab
Study Phase: Phase 4
Randomized Study of Different Non-myeloablative Conditioning Regimens With Hematopoietic Stem Cell Support in Patients With Scleroderma (Autologous Systemic Sclerosis Immune Suppression Trial - II ASSIST-IIb)
Randomized Study of Different Non-myeloablative Conditioning Regimens With Hematopoietic Stem Cell Support in Patients With Scleroderma (Autologous Systemic Sclerosis Immune Suppression Trial - II ASSIST-IIb)
Enrollment Status: Terminated
Publish Date: July 23, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

59 Total Publications

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 12, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

University Of Illinois Chicago Physician Group (Uicpg)

1801 W Taylor St, 
Chicago, IL 
 (3.5 miles away)
312-355-1700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nadera Sweiss is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Sweiss is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Neurosarcoidosis, Rheumatoid Arthritis (RA), and Scleroderma. Dr. Sweiss is currently accepting new patients.

Expertise in
18
conditions
Dr. Robert S. Katz
Rheumatology
Expertise in
18
conditions
Dr. Robert S. Katz
Rheumatology
Referral may be required
Before you request

Office

1725 W Harrison St Ste 365, 
Chicago, IL 
 (4.0 miles away)
312-942-2159
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Katz is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Katz is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Arthritis, Rheumatoid Arthritis (RA), and Postmenopausal Osteoporosis. Dr. Katz is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

University Of Chicago Medical Center

5841 S Maryland Ave, 
Chicago, IL 
 (7.4 miles away)
773-702-6885
Languages Spoken:
English
Accepting New Patients

Timothy Niewold is a Rheumatologist practicing medicine in Chicago, Illinois. Dr. Niewold is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Dermatomyositis, Polymyositis, and Lupus Nephritis. Dr. Niewold is currently accepting new patients.

Frequently Asked Questions about Dr. Eric M. Ruderman

How do I make an appointment with Dr. Eric M. Ruderman?

You can book an appointment with Dr. Eric M. Ruderman by calling their office at 312-695-8628. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eric M. Ruderman a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eric M. Ruderman is classified as an Elite expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eric M. Ruderman specialize in?

While Dr. Eric M. Ruderman is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Psoriatic Arthritis, and Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Eric M. Ruderman participate in research or clinical trials?

Yes. Dr. Eric M. Ruderman has published 59 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Eric M. Ruderman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eric M. Ruderman accept my insurance?

Dr. Eric M. Ruderman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 312-695-8628 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ruderman's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 29 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile